Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin versus pioglitazone in drug-naive patients with type 2 diabetes

被引：0
|
作者：
Perez-Monteverde, A. [1 ]
Seck, T. [2 ]
Xu, L. [2 ]
Liu, G. [2 ]
Lee, M. A. [2 ]
Sisk, C. McCrary [2 ]
Williams-Herman, D. E. [2 ]
Kaufman, K. D. [2 ]
Goldstein, B. J. [2 ]
机构：
[1] Ctr Med Docente Trinidad, Caracas, Venezuela
[2] Merck Sharp & Dohme Corp, Rahway, NJ USA
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
820
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naive patients with type 2 diabetes
    Perez-Monteverde, A.
    Seck, T.
    Xu, L.
    Lee, M. A.
    Sisk, C. M.
    Williams-Herman, D. E.
    Engel, S. S.
    Kaufman, K. D.
    Goldstein, B. J.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (09) : 930 - 938
  • [2] Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients with Type 2 Diabetes
    Cuddihy, Robert M.
    Russell-Jones, David
    Hanefeld, Markolf
    Kumar, Ajay
    Gonzalez, Jose G.
    de Teresa, Luis
    Boardman, Marilyn
    Chan, Melanie
    Wolka, Anne M.
    Porter, Lisa
    DIABETES, 2011, 60 : A77 - A77
  • [3] Fixed-dose combination of sitagliptin and metformin for the treatment of type 2 diabetes
    Reynolds, Jonathan K.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2009, 2 : 127 - 134
  • [4] Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Lobeglitazone in Drug-Naive Patients with Type 2 Diabetes
    Kim, Kyoung Min
    Lee, Seo Young
    Lee, Ji Hyun
    Lee, Dong Hwa
    Oh, Tae Jung
    Jang, Hak Chul
    Lim, Soo
    DIABETES, 2017, 66 : A346 - A346
  • [5] Fixed-dose combination therapy for type 2 diabetes: sitagliptin plus pioglitazone
    Bailey, Clifford J.
    Green, Brian D.
    Flatt, Peter R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (08) : 1017 - 1025
  • [6] Efficacy and safety of linagliptin/metformin fixed-dose combination as initial therapy in drug-naive Asian patients with type 2 diabetes
    Gong, Y.
    Mu, Y.
    Fan, B.
    Hehnke, U.
    Pan, C.
    DIABETOLOGIA, 2015, 58 : S388 - S388
  • [7] Initial combination of metformin, sitagliptin, and empagliflozin in drug-naive patients with type 2 diabetes: Safety and metabolic effects
    Lim, Soo
    Sohn, Minji
    Shin, Yujin
    Ferrannini, Ele
    DIABETES OBESITY & METABOLISM, 2022, 24 (04): : 757 - 762
  • [8] Efficacy and safety of fixed dose combination of Sitagliptin, metformin, and pioglitazone in type 2 Diabetes (IMPACT study): a randomized controlled trial
    Mondal Aashish
    Naskar Arindam
    Sheelu Shafiq Siddiqi
    Deepak Bhosle
    V. J. Mallikarjuna
    Dange Amol
    Sorate Sanket
    Gavali Omkar
    Patel Parth
    Hasnani Dhruvi
    Prasad Durga
    Dalwadi Pradeep
    Kumar Suresh
    Pathak Vaishali
    Chaudhari Mayura
    Basu Indraneel
    Shembalkar Jayashri
    Fariooqui Arif
    S. K. Raghavendra
    Varade Deepak
    Thakkar Ravindra
    Bhanushali Shaishav
    Gaikwad Vijay
    Kamran Khan
    V. V. Mahajani
    A. D. Sharma
    Mayur Mayabhate
    R. R. Pawar
    A. S. Aiwale
    Shahavi Vinayaka
    Clinical Diabetes and Endocrinology, 10 (1):
  • [9] Sitagliptin/Metformin Fixed-Dose CombinationIn Patients with Type 2 Diabetes Mellitus
    Claudine M. Chwieduk
    Drugs, 2011, 71 : 349 - 361
  • [10] Sitagliptin/Metformin Fixed-Dose Cambination In Patients with Type 2 Diabetes Mellitus
    Chwieduk, Claudine M.
    DRUGS, 2011, 71 (03) : 349 - 361
12345